28 October 2020 | News
The demand for lactoferrin as a functional ingredient with health value is expected to grow over the long term globally
Image credit: Businesswire
Tokyo based Morinaga Milk Industry (Morinaga Milk) has announced that its subsidiary MILEI GmbH (MILEI), which has the largest share of the global market in terms of production volume of the functional ingredient lactoferrin, will increase more than double its production capacity with the aim to enhance its lactoferrin production.
According to data for 2019 released by Absolute Reports:
As a functional ingredient for infant formula, supplements, and other foods, the demand for lactoferrin has been growing particularly in Western countries and Asia. Considering the increasing attention towards health and nutrition, the demand for lactoferrin as a functional ingredient with health value is expected to grow over the long term globally. Morinaga Milk Group considers lactoferrin as an important functional ingredient to support people’s health and nutrition worldwide and has been conducting fundamental research and seeking commercial applications for over six decades.
Morinaga Milk Group is aiming to increase the sales of its own lactoferrin-related products with expanding production capacity in MILEI, and will flexibly respond to the long-term increasing demand for lactoferrin. Having the largest production share of lactoferrin, Morinaga Milk Group will increase the production of MILEI and contribute to the well-being of people.
MILEI is based in the southern German city of Leutkirch, where its production facilities are located. Founded in 1972, MILEI has a history of almost five decades since its start of production in 1975. MILEI offers lactoferrin, whey protein concentrate, lactose, and other dairy ingredients mainly in Europe and Asia.